Risk Factors for Pulmonary Hypertension in Scleroderma

Grant number: 1038612 | Funding period: 2012 - 2014

Completed

Abstract

I am a rheumatologist treating systemic sclerosis, a life threatening illness. A serious complication is high blood pressure in the lungs, or pulmonary arterial hypertension. Unfortunately this problem is often detected too late. My goal is to be able to identify those patients who will develop this condition so that they can access life saving treatment at the earliest possible time in order to improve their quality of life and increase their chance of survival.

Related publications (3)

Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension

V Thakkar, M Nikpour, WM Stevens, SM Proudman

2015-03-01

Pulmonary arterial hypertension (PAH) is a leading cause of morbidity and mortality in patients with systemic sclerosis (SSc). App..

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis

Y Hao, V Thakkar, W Stevens, K Morrisroe, D Prior, C Rabusa, P Youssef, E Gabbay, J Roddy, J Walker, J Zochling, J Sahhar, P Nash, S Lester, M Rischmueller, SM Proudman, M Nikpour

2015-01-18

Introduction: There is evidence that early screening for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) improve..

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: A cohort study

V Thakkar, W Stevens, D Prior, P Youssef, D Liew, E Gabbay, J Roddy, JG Walker, J Zochling, J Sahhar, P Nash, S Lester, M Rischmueller, SM Proudman, M Nikpour

2013-11-19

Introduction: Pulmonary arterial hypertension (PAH) is a major cause of mortality in systemic sclerosis (SSc). Screening guideline..

University of Melbourne Researchers

Mandana Nikpour